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Abstract 59 
 60 
The genetic features of isolated populations can boost power in complex-trait 61 
association studies, and an in-depth understanding of how their genetic 62 
variation has been shaped by their demographic history can help leverage 63 
these advantageous characteristics. Here, we perform a comprehensive 64 
investigation using 3059 newly-generated low-depth whole-genome 65 
sequences from eight European isolates and two matched general populations, 66 
together with published data from the 1000 Genomes Project and UK10K. 67 
Sequencing data give deeper and richer insights into population demography 68 
and genetic characteristics than genotype-chip data, distinguishing related 69 
populations more effectively and allowing their functional variants to be 70 
studied more fully. We demonstrate relaxation of purifying selection in the 71 
isolates, leading to enrichment of rare and low-frequency functional variants, 72 
using novel statistics, DVxy and SVxy.  We also develop an isolation-index (Isx) 73 
that predicts the overall level of such key genetic characteristics and can thus 74 
help guide population choice in future complex-trait association studies.  75 
 76 
 77 
Introduction 78 
 79 
Population variation in disease susceptibility has been shaped by environment, 80 
demography and evolutionary history. Isolated populations (isolates) have 81 
generally experienced bottlenecks and strong genetic drift, so by chance some 82 
deleterious rare variants have increased in frequency while some neutral rare 83 
variation is lost, both helpful characteristics for the discovery of novel rare variant 84 
signals underpinning complex traits1-3. Studies to date have focused on individual 85 
isolates and have identified several disease-associated signals4-12. However, isolates 86 
differ in the time when they became isolated, their initial population size, the level 87 
of gene flow from outside and other historical demographic factors, and 88 
consequently also differ in their power for association studies2. We thus generate 89 
and analyze low-depth (4x-10x) whole-genome sequences (WGS) from eight cohorts 90 
drawn from isolated European populations and compare each isolate with the 91 
closest non-isolated (general) population, for which we also generate or access WGS 92 
data. We then investigate empirically how these historical differences influence the 93 
population-genetic properties of isolates, and frame these insights in terms of their 94 
consequences for study design in complex trait association studies.  95 
 96 
 97 
Results 98 
 99 
Samples, sequencing and QC. The dataset includes newly-generated low-depth 100 
(4x-10x) WGS from eight cohorts drawn from isolated European populations: one 101 
each from Kuusamo in Finland (FIK) and Crete in Greece (GRM13), four from Friuli-102 
Venezia Giulia in Italy (IF1, IF2, IF3 and IF414), and one each from Val Borbera in 103 
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Italy (IVB15) and the Orkney Islands in the UK (UKO16); and the closest non-isolated 104 
(general) population: Finland (FIG9), Greece (GRG), together with publicly available 105 
data for Italy (ITG17) and UK (UKG18) (Fig. 1a and Supplementary Table 1). We 106 
generated a superset of variants called in these cohorts and all 26 population 107 
samples in the 1000 Genomes Project Phase 317, and performed multi-sample 108 
genotype calling across all 9375 samples (3059 from the current study, 2353 from 109 
the 1000 Genomes Project Phase 3 release, and 3781 from UK10K). Both individual 110 
population and amalgamated genotype call data, which have greater than 99% 111 
concordance with genotyping data (Supplementary Table 2), are available to the 112 
scientific community (Data availability).   113 
 114 
General description of the variants in the isolates. We identified approximately 115 
12.2 million (M) variants with minor allele frequency (MAF) ≤2% (rare), 5.5M with 116 
MAF >2-≤5% (low-frequency) and 8.3M variants with MAF >5% (common) across 117 
the 10 populations newly sequenced here (eight isolates, GRG and FIG). Of these, 118 
10.5%, 0.7% and 0.3%, respectively, are novel (Table 1 and Supplementary Table 3). 119 
As expected, most of the isolates have lower numbers of variant sites per genome 120 
than their closest general population (Supplementary Fig.1, Supplementary Table 5). 121 
We find ~188,000-~513,000 variants that are common with MAF >5.5% in each 122 
isolate but with MAF ≤1.4% in its closest general population (Table 1); ~30,000-123 
122,000 of these per isolate have frequency ≤1.4% in all the general samples 124 
studied, among which ~150-~700 in coding regions and ~500-~2800 genome-wide 125 
are deleterious (Supplementary Table 4).  These common and low-frequency 126 
variants are thus useful markers for whole-genome association studies in these 127 
populations and some of them (if absent from the general population) could 128 
potentially lead to novel association signals. They include known examples such as 129 
rs76353203 (R19X) in APOC3 in GRM, which is associated with high-density 130 
lipoprotein and triglyceride levels6. 131 
 132 
Population-genetic analyses in the isolates. Previous population-genetic studies 133 
of isolates have, with some exceptions11,19, been based on common variants found 134 
on genotyping arrays, and have illustrated general characteristics such as low 135 
genetic diversity and longer shared haplotypes9,13-15,19,20. Rare variants discovered 136 
from sequencing are on average more recent in origin than common variants21 and  137 
therefore more powerful for distinguishing closely-related populations and more 138 
informative about recent demographic history. We find that isolates are, as expected, 139 
genetically close to their matched general population in principal component 140 
analyses (PCA), ADMIXTURE22 and TreeMix23 using common variants (Fig. 1b, 141 
Supplementary Figs. 2-5 and Supplementary Table 6), but PCA using rare and low-142 
frequency variants, as found previously24, distinguishes them more clearly from the 143 
general population and also from other isolates, particularly among the Italian 144 
samples (Fig. 1c, Supplementary Fig. 2). The majority of sharing of variants present 145 
just twice across all samples of 36 individuals from each population (f2 variants21) 146 
takes place within the same population, and the isolates generally share more with 147 
their closest general population than with other populations. This latter trend, 148 
however, is not apparent for IF1-IF4, who show little sharing with any other 149 
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population, pointing to a greater level of isolation and lower level of gene flow with 150 
their general population (Fig. 1d, lower triangle and Supplementary Fig. 7), which is 151 
confirmed by f3-statistics25 comparing with a worldwide population panel of HGDP-152 
CEPH samples using common SNPs (Supplementary Fig. 6). f3-f10 variant sharing 153 
demonstrates sharing by ITG and IVB with both Greek and UK populations (Fig. 1d, 154 
upper triangle and Supplementary Fig. 7), potentially indicative of their more 155 
ancient heritage. 156 
 157 
Population demographic history. All populations studied here, both isolates and 158 
general, appear to have shared a comparable effective population size (Ne)history 159 
before 20 thousand years ago (KYA) based on the multiple sequentially Markovian 160 
coalescent (MSMC) method26 (Supplementary Fig. 9). The isolates diverged from 161 
their general populations within the last ~5000 years based on LD estimations27 162 
(Supplementary Table 7 and Supplementary Fig. 8) and yet had sharp decreases in 163 
their population sizes in more recent times as estimated using inferred long 164 
segments of identity by descent (IBD)28 (Fig. 1e, f and Supplementary Fig.10). 165 
Different isolates also split from their respective general populations at different 166 
times. For example, IF1-IF4 split from ITG ~4-5 KYA, while most other isolates split 167 
from their general populations within the last ~1,000 years (Supplementary Table 168 
7).   169 
 170 
The different demographic histories of different isolates should lead to different 171 
genetic characteristics. To summarize these features in a single quantitative 172 
measure that can be calculated from genotype data, as well as sequence data, we 173 
developed an isolation index (Isx) which combines information on the divergence 174 
time from the general population (Tdg), Ne and migration rate (M), such that early-175 
divergence-time isolates with small Ne and low M have a high Isx value (Fig. 2a and 176 
Supplementary Fig. 11). The different isolates show different Isx values: IF1, IF2, IF3 177 
and IF4 have the highest, while IVB has the lowest (Supplementary Table 8). Isx 178 
values are highly correlated with other population-genetic characteristics (e.g. Fig. 179 
2b, c, Supplementary Table 11), such as genome-wide pairwise FST between isolates 180 
and their matching general population (reflecting the genetic drift of the isolates) 181 
(Supplementary Fig. 12), the total length and number of runs of homozygosity 182 
(ROH) (Supplementary Fig. 13), inbreeding coefficient (F) (Supplementary Fig. 14) 183 
and length of LD (Supplementary Figs. 15-16 and Supplementary Table 9, 10). All 184 
these characteristics are correlated, but the pairwise correlation coefficients show 185 
that Isx is a slightly better overall predictor of the other measures than any single 186 
existing measure (Fig. 2c, Supplementary Fig. 17 and Supplementary Table 11); 187 
moreover, it is potentially more robust to confounding factors as it is calculated 188 
from three demographic parameters, while the others are all based on single 189 
measurements.  190 
 191 
Purifying selection analyses. Several lines of evidence suggest relaxed purifying 192 
selection in the isolates due to their reduced Ne, although as expected we do not 193 
detect substantially increased genetic load per genome using the Rxy statistic29 194 
based on all of the variants in the genomes (Fig. 3a and Supplementary Table 12). 195 
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First, we see different levels of enrichment of low-frequency functional variants in 196 
isolates (Fig. 3b and c, Supplementary Tables 13 and14, Supplementary Figs. 18a) 197 
quantified by a new statistic, DVxy-coding, developed here (DV: drifted variants). 198 
DVxy-coding measures the ratio of functional coding variants (missense plus loss-of-199 
function (LoF)) in isolates compared to the closest general population (and vice-200 
versa), adjusted for the corresponding ratios of intergenic variants in order to 201 
correct for the effect of genetic drift. We applied this only to a subclass of DVs, 202 
defined as low-frequency (2-5%, the best choice according to the sample size we 203 
have) in any isolate, yet at least three-fold higher than in the closest general 204 
population (and vice versa). We find that DVxy-coding is >1 in all isolates and <1 in 205 
all general populations (Fig. 3c, Supplementary Fig. 18a and Supplementary Table 206 
13). We also calculated a similar DVxy-wg statistic by stratifying whole-genome 207 
variants according to their combined annotation dependent depletion (CADD) score 208 
(0-5, neutral variants; 5-10, mildly deleterious; 10-20, deleterious; and >20, highly 209 
deleterious; these cut-off choices balance the number of variants in each bin to allow 210 
us comparable statistical power among all bins, although the conclusions are robust 211 
to the particular cut-off values chosen and different bins (Supplementary Figs. 18b  212 
and Supplementary Fig. 19)). The DVxy-wg values are differentiated for variants 213 
with CADD score of 10-20 and significantly so (assessed using the jack-knife 214 
bootstrap method) for ones with CADD scores >20, with DVxy-wg values >1 in all 215 
isolates and <1 in all general populations (Fig. 3b, Supplementary Fig. 18b and 216 
Supplementary Table 14). This demonstrates enrichment of low-frequency 217 
functional variants, both coding and genome-wide with CADD score >10, in the 218 
isolated populations. Moreover, both DVxy-coding and DVxy-wg values are 219 
correlated with Isx, suggesting that different isolation characteristics lead to 220 
different levels of enrichment of functional variants.  221 
 222 
We also investigated the relaxation of purifying selection by assessing functional 223 
(missense) singleton variants (SV) pooled for all of the genes that have at least one 224 
singleton missense or synonymous variant in a pair of populations (one isolate and 225 
its general population), correcting with pooled synonymous variants (SVxy statistic,). 226 
We find a substantial deviation from 1 for functional singletons in all of the isolates 227 
(Fig. 3d and Supplementary Table 15), with SVxy values positively correlating with 228 
Isx (Fig. 2c and Supplementary Fig. 20). We also find that the proportion of relaxed 229 
essential genes30 with SVxy >1 in isolates is significantly higher than in the general 230 
population (Supplementary Table 15). Such rare and low-frequency drifted 231 
functional variants, measured by both DVxy and DVxy, are particularly relevant for 232 
boosting the power of association studies6.  233 
 234 
Positive selection analyses. We do not find convincing evidence for positive 235 
selection in any isolate using deltaDAF31, PCAdapt32 or SDS33, although we do 236 
identify some highly differentiated variants (Supplementary Fig. 21 and 237 
Supplementary Tables 16,17), including in the protein-coding genes ALK, SPNS2, 238 
SLC39A11 and ACSS2, which can nevertheless be accounted for by drift.  239 
Interestingly, we also find six highly-differentiated variants shared between 240 
different isolates from Italy, IF2, IF3 and IF4, but interpret them as likely to result 241 
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from drift or positive selection for the ancestral allele in the ITG (Supplementary 242 
Table 17). We find that the SDS method has little power in our samples because of 243 
their small size, and failed to detect selection even at the lactose tolerance SNP in 244 
the UKO, a known strong signal of recent selection (Supplementary Fig. 22). 245 
 246 
 247 
Discussion  248 
 249 
Isolated populations have special characteristics that can be leveraged to increase 250 
the power of association studies, as several previous studies have shown19,34. 251 
Nevertheless, only a small proportion of functional variants have increased in 252 
frequency in any one isolate, so multiple isolates must be investigated to reveal the 253 
full diversity of associated variants. Here, we probed an extended allele frequency 254 
spectrum of variants potentially underpinning human complex disease through the 255 
analysis of whole-genome sequence data in multiple isolates matched to nearby 256 
non-isolated populations, capturing common, low-frequency and rare variants. We 257 
quantified different levels of isolation resulting from different demographic 258 
histories and have demonstrated that the Isx statistic, calculated even from SNP-chip 259 
data, reliably captures these relevant features. This study provides a systematic 260 
evaluation of the genetic characteristics of multiple European isolates and for the 261 
first time empirically demonstrates enrichment of rare functional variants across 262 
multiple isolates. With the advent of large-scale whole-genome sequencing, studies 263 
in isolates are poised to continue as major contributors to our understanding of 264 
complex disease etiology.  265 
 266 
 267 
Methods 268 
 269 
Dataset and variant calling: The dataset includes 3059 whole-genome low-depth 270 
sequences generated at The Wellcome Trust Sanger Institute using the Illumina 271 
Genome Analyzer II and Illumina HiSeq 2000 platforms, as well as 100 high-depth 272 
sequences from the Illumina HiSeq X Ten (Fig. 1a and Supplementary Table 1). 273 
Informed consent was obtained from all subjects and the study was approved by the 274 
HMDMC (Human Materials and Data Management Committee) of the Welcome Trust 275 
Sanger Institute. The multi-sample genotype calling across all of the low-coverage 276 
sequencing data from the current study, as well as 2353 from the 1000 Genomes 277 
Project Phase 3 release, and 3781 from UK10K (a total of 9375) was performed with 278 
the defined site selection criteria (Supplementary Note). Genotype likelihoods were 279 
calculated with samtools/bcftools (0.2.0-rc9) and then genotypes were called and 280 
phased using Beagle v4 (r1274)35. We assessed the performance of the genotype 281 
calling from the low coverage data using the available genotype chip data for a 282 
subset of the cohorts consisting of 4665 individuals, and calculated the discordance 283 
rates on chromosome 20 separately for the categories REF-REF, REF-ALT and ALT-284 
ALT. 285 
 286 
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The sample sizes are very different across these collections, and we used three 287 
different standard-sized subsets of the samples for different analyses: (1) the whole 288 
dataset; (2) the sample-size-matched dataset, obtained either by randomly selecting 289 
samples from general population to match the isolated population (for example, we 290 
randomly select 377 from FIG to match FIK), or by randomly selecting a subset of 291 
the isolated population to match the general population (for example, we randomly 292 
select 108 IVB to match the general population ITG); (3) the minimum-sample-size 293 
dataset of 36 individuals per population. By doing this, we maximize the use of the 294 
data for different analyses, and we specify which dataset is used for each analysis. 295 
The sequencing depth is also different across different populations, within a 2.5-fold 296 
range (apart from GRG, in which variants were called differently, details in 297 
Supplementary Notes), and we allowed for these differences when interpreting the 298 
results. 299 
 300 
Variant counts: We first re-annotated all variants using the Variant Effect Predictor 301 
(VEP) annotation from Ensembl 76 with the “- pick” option, which gives one 302 
annotation per variant. We then performed variant counting at both the population 303 
and individual level, stratifying by functional categories and frequency bins. These 304 
counts were either plotted in figures or summarized as median values in tables. We 305 
carried out these analyses using both the sample-size-matched dataset and the 306 
minimum-sample-size dataset. 307 
 308 
Population-genetic analyses: We used the whole dataset for the analyses in this 309 
section, unless otherwise specified. Principal component analyses (PCAs) were 310 
performed separately with common variants or rare variants using EIGENSTRAT 311 
v.50136.  Shared ancestry between the populations studied here was evaluated using 312 
ADMIXTURE v1.2222. The relationships between the populations studied here, 313 
combined with worldwide populations from the HGDP-CEPH panel37, were also 314 
examined using ancestry graph analyses implemented in TreeMix v.1.1223. We also 315 
used formal test of f3-satitisitcs25 to investigate population mixture in the history of 316 
the populations studied here, as well as worldwide populations from the HGDP-317 
CEPH panel. Rare f2 variants (with only two copies of the alternative allele in the 318 
minimum-sample-size dataset) and moderately rare f3-10 variants (3-10 copies of the 319 
alternative allele in the same dataset) are particularly informative for investigating 320 
recent human history21. We investigated the sharing pattern of these two types of 321 
variant by summing all f2 variants or any random two alleles of the f3-10 variants 322 
shared by pairs of individuals. We plotted the results as a heat map using the image¹ 323 
function from the base R package (https://stat.ethz.ch/R-manual/R-324 
devel/library/graphics/html/image.html). Variants were aggregated by pair of 325 
individuals using the ‘count’ function of the plyr package, then arranged in matrix 326 
form and colorized using ‘colorRampPalette’ from the colorspace package 327 
(https://cran.r-project.org/web/packages/colorspace/index.html). Runs of 328 
homozygosity (ROH),  inbreeding coefficient (F) as well as the length of LD-blocks 329 
were calculated in PLINK, and finally genome-wide FST values between isolates and 330 
their general populations were calculated with the software 4P38 using the 331 
minimum-sample-size dataset.  332 
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 333 
Demographic inferences: LD-based39-41 demographic inference was performed in 334 
the NeON R package27 using the minimum-sample-size dataset; the median and 335 
confidence interval were estimated using the 50th, 5th and 95th percentiles of the 336 
distribution of long-term Ne in each time interval. We used the multiple sequentially 337 
Markovian coalescent (MSMC) method26 to infer demographic changes before 338 
20,000 years ago using four individual sequences from each population. In order to 339 
account for some loss of heterozygous sites in the low-depth data, we used a slow 340 
mutation rate of 0.8 x 10-8 mutations per nucleotide per generation and a longer 341 
generation time of 33 years. We then estimated more recent demographic changes 342 
(from the present to ~9,000 years ago) using IBDNe28 with the minimum-sample-343 
size dataset. We used IBDseq42 to detect IBD segments in sequence data from 344 
chromosome 2 in all populations. We then used IBDNe with the default parameters 345 
and a minimum IBD segment length of 2 centiMorgan (cM) units. We assumed a 346 
generation time of 29 years. 347 
 348 
Isolation index: In order to quantify the different isolation levels of different 349 
isolates, we developed an index that combines three demographic parameters: (a) 350 
Tdg, (b) Ne, and (c) the level of private isolate ancestry (M). We call this estimate the 351 
Isolation index (Isx). It is defined as: 352 
 353 
ܫݏݔ = log(ܶ݀݃(100 ∗ ܯ)
ଶ)
log(ܰ݁)  
 354 
Both Tdg and Ne were inferred from the LD-based method using the NeON R 355 
package27. M is difficult to estimate directly from SNP genotype data, so here we 356 
estimated the difference of shared ancestral components between an isolate and its 357 
general population from ADMIXTURE analysis. We ran ADMIXTURE with only one 358 
isolate and it closest general population using K=2. We then estimated the difference 359 
in the means of ancestry between the isolate and its general population. The M 360 
parameter was defined as Delta Ancestry. 361 
 362 
Rxy analysis: Rxy statistics29 between each pair of populations (an isolate and its 363 
closest general population) for different functional categories were calculated using 364 
the matched-sample-size data for missense and LoF variants, including stop gain, 365 
splice donor and acceptor variants, using synonymous variants as controls (we did 366 
not use intragenic variants as control because of the ascertainment in the ITG which 367 
has high-depth exome sequences and low depth for the rest of the genome). We also 368 
calculated Rxy statistics for variants with CADD scores43 greater than 10 and 20, 369 
using variants with CADD scores less than 5 as controls. The mean and standard 370 
deviation for each Rxy value were obtained from 100 bootstraps.  371 
 372 
DVxy analysis: A new statistic, DVxy, was developed to quantify the enrichment of 373 
low-frequency functional variants in the isolates using both the matched-sample-374 
size and minimum-sample-size datasets. It calculates the proportion of functional 375 
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variants in each isolate compared with its general population, correcting for genetic 376 
drift at the same time. We calculated DVxy specifically for the subset of variants with 377 
DAF 2-5% in the isolate, and at least three times lower in its closest general 378 
population, or vice-versa. We called these variants “drifted variants” (DV). DVxy was 379 
calculated for both coding regions and whole genomes.  380 
 381 
For coding variants, we defined missense or missense plus LoF variants as 382 
functional variants.  We counted the number of functional DVs and neutral 383 
(intergenic) DVs in each isolate (population x) and the corresponding general 384 
population (population y). The ratio between the fraction of DV variants from the 385 
isolated population (corrected by the count of intergenic variants) and the 386 
corresponding fraction of DV variants from its general population was defined as 387 
the DVxy statistic. If DVxy is equal to 1, there is no enrichment for the functional DVs 388 
in the isolate; less than 1 indicates depletion, and greater than 1 indicates 389 
enrichment. 390 
                    391 
ܦܸݔݕ_ܿ݋݀݅݊݃ =
%ܦܸݔ ݉݅ݏݏ݁݊ݏ݁
%ܦܸݔ ݅݊ݐ݁ݎ݃݁݊݅ܿ 
%ܦܸݕ ݉݅ݏݏ݁݊ݏ݁
%ܦܸݕ ݅݊ݐ݁ݎ݃݁݊݅ܿ
൙   
 392 
For the whole genome, we used different CADD score cut-offs and bins. We 393 
calculated a DV statistic by stratifying the variants according to their CADD scores 394 
(0-5, neutral variants; 5-10, mildly deleterious; 10-20, deleterious; and greater than 395 
20, highly deleterious) for each isolate and its closest general population. We finally 396 
calculated a ratio of the fraction of DV variants (from each class) between the isolate 397 
and its general population, and vice-versa. The following formula shows the DVxy-398 
wg calculation for variants with CADD score between i (isolate) and j (general 399 
population). 400 
 401 
ܦܸݔݕ஼஺஽஽(௜௝) = % ܦܸݔ (ܥܣܦܦ ݅ − ݆) %ܦܸݕ(ܥܣܦܦ ݅ − ݆)൘  
 402 
The 95% confidence interval for each calculation was obtained by randomly 403 
sampling data from 20 chromosomes 100 times.  404 
 405 
SVxy analysis: We further investigated the relaxation of purifying selection in the 406 
isolated populations using singleton variants. Here, we also used the minimum-407 
sample-size dataset. Another new statistic, SVxy, was developed to measure the ratio 408 
of missense vs synonymous singletons per gene in each population, as well as the 409 
ratio of the sum of singletons in all genes which have at least one singleton in the 410 
pair of the populations (one isolate and one general population). We counted the 411 
number of missense singletons and synonymous singletons per gene in each 412 
population, and SVgene was calculated as: 413 
 414 
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SVgene = (SV missense count +1)/ (SV synonymous count +1) 415 
 416 
SVgene >1 indicates relaxation of purifying selection; SVgene = 1 indicates 417 
neutrality; and SVgene <1 indicates purifying selection.  418 
 419 
We then divided the gene list into essential genes30 and non-essential genes (the 420 
rest), and calculated a statistic, GSV, for each population, defined as: 421 
 422 
GSV = percentage of essential genes with SVgene >1/percentage of non-essential 423 
genes with SVgene >1 424 
 425 
We finally calculated a statistic, SVxy, which is the ratio of SVpop of each isolate to 426 
SVpop of its general population. SVpop for each isolate and its general population 427 
was calculated using all genes which have at least one singleton in the pair of the 428 
populations and defined as SVpop = Σ (SV missense counts)/Σ(SV synonymous 429 
counts). 430 
 431 
We used the same annotation as in the variant counts. We calculated a confidence 432 
interval for each estimate using bootstrapping of 80% of the genes 100 times. 433 
 434 
Correlation analyses: We calculated pair-wise correlation coefficients between the 435 
Isx values, population-genetic measurements ROH, F, FST, and number and length of 436 
LD blocks, as well as the newly-developed statistics DVxy and SVxy using the 437 
Pearson correlation in R. 438 
 439 
Positive selection analyses: We calculated genome-wide pairwise derived allele 440 
frequency differences (deltaDAF) for each pair of populations (an isolate and its 441 
general population) as described previously31 using the matched-sample-size 442 
dataset. We also carried out PCAdapt analyses32 for each pair of populations using 443 
the whole dataset. Both analyses look for high derived allele frequency variants in 444 
the isolates, and will not be affected by sample size. Finally, we ran the singleton 445 
density score (SDS) method33 using the whole UKO and UKG datasets, which have 446 
the largest sample sizes for both isolate and its general population, and thus the 447 
greatest power for this method. 448 
 449 
Data availability: 450 
 451 
Amalgamated genotype calls across all populations studied are available through 452 
the European Genome/Phenome Archive (EGAD00001002014) with Data Access 453 
Agreement described in the Supplementary Information. 454 
 455 
 456 
 457 
 458 
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Figure legends 593 
 594 
 595 
Fig. 1. General characteristics and demographic history of isolated and matched 596 
general populations. a. Geographical locations of samples. The base map was plotted 597 
in R using the mapdata package and circles were added using Photoshop. b. PCA 598 
using common variants. c. PCA using low-frequency variants. d. Sharing of rare 599 
variants within and between populations. Upper left triangle: f2 variants; lower right 600 
triangle f3-f10 variants. e. Effective population size (Ne) inferred from IBDNe for UKO 601 
and UKG during the past 9 KY. f. The lowest Ne inferred by IBDNe for all populations 602 
for the past 3KY, plotted as a function of the time at which it occurred.  603 
 604 
Fig. 2. Isolation index (Isx) and its correlation with other genetic measures. a. 605 
Information summarized in Isx. b. Example of the correlation between Isx and other 606 
statistics, here DVxy-coding. c. Summary of the correlations between Isx and other 607 
population-genetic statistics. All the correlation coefficients are high and statistically 608 
significant.  609 
 610 
Fig. 3. Purifying selection in the isolates and general populations. a. Rxy-missense 611 
statistic in each isolate, showing no evidence for increased genetic load in the 612 
isolates. The mean and standard deviation for each Rxy value from 100 bootstraps 613 
are shown. b. DVxy-wg (DVxy-whole genome) statistic in isolates and general 614 
populations, stratified by CADD score, showing enrichment of highly-functional low-615 
frequency variants. c. DVxy-coding statistic in isolates and general populations, 616 
showing enrichment of low-frequency missense variants in isolates. d. SVxy-617 
missense statistic in each isolate, showing relaxation of purifying selection in 618 
isolates in singletons. The standard errors for both DVxy and SVxy were calculated 619 
by randomly sampling data from 20 chromosomes 100 times. All of these analyses 620 
are based on the minimum-sample-size dataset (36 individuals from each 621 
population). 622 
  623 
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Tables: 624 
  625 
Table 1. Summary of variants discovered in this study 626 
 627 
 628 
‘Novel’ variants are those not found in 1000 Genomes Project Phase 3 or UK10K 629 
project. *Variants that are common (minor allele frequency, MAF ≥5.6%, alternative 630 
allele count ≥ 4) in an isolated population but not common (MAF <1.4%, alternative 631 
allele count ≤ 1) in its closest general population. **Variants that are common (MAF 632 
≥5.6%, alternative allele count ≥ 4) in an isolated population but not (MAF <1.4%, 633 
alternative allele count ≤ 1) in any of the general populations. ***Different variant 634 
calling procedure in this population.  635 
 636 
 637 
 638 
 639 
POP n average 
depth 
MAF ≤2% MAF >2-≤5% MAF >5% Novel 
common 
SNPs in 
isolate* 
Novel 
common 
SNPs in 
isolate** 
   total novel
% 
total novel
% 
total novel
% 
  
FIK 377 4x 4,066,373 10.90 1,553,076 1.20 6,025,077 0.70 190,527 70,579 
FIG 1564 6x 6,548,833 11.80 1,540,915 0.80 6,053,704 0.70 n.a. n.a. 
GRM 249 4x 5,129,513 7.20 1,447,981 1.10 6,111,923 0.80 513,272 49,884 
GRG*** 99 10-30x 3,757,110 n.a. 1,321,955 n.a. 5,842,537 n.a. n.a. n.a. 
IF1 60 4-10x 1,456,881 1.30 1,420,929 1.30 5,890,714 0.80 320,191 119,157 
IF2 45 4-10x 1,063,098 1.30 1,554,145 1.00 6,001,568 0.80 273,694 94,496 
IF3 47 4-10x 961,059 1.30 1,455,284 1.10 6,068,304 0.80 299,603 107,281 
IF4 36 4-10x 1,030,673 1.30 1,124,789 1.10 6,001,625 0.80 308,356 122,254 
IVB 222 6x 4,857,767 1.60 1,396,799 0.80 6,112,476 0.80 188,972 30,284 
UKO 397 4x 5,963,416 11.70 1,471,782 0.80 6,047,383 0.80 193,300 36,512 
Total 3096  12,218,797 10.50 5,503,179 0.70 8,301,524 0.30  
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Abstract 59 
 60 
The genetic features of isolated populations can boost power in complex-trait 61 
association studies, and an in-depth understanding of how their genetic 62 
variation has been shaped by their demographic history can help leverage 63 
these advantageous characteristics. Here, we perform a comprehensive 64 
investigation using 3059 newly-generated low-depth whole-genome 65 
sequences from eight European isolates and two matched general populations, 66 
together with published data from the 1000 Genomes Project and UK10K. 67 
Sequencing data give deeper and richer insights into population demography 68 
and genetic characteristics than genotype-chip data, distinguishing related 69 
populations more effectively and allowing their functional variants to be 70 
studied more fully. We demonstrate relaxation of purifying selection in the 71 
isolates, leading to enrichment of rare and low-frequency functional variants, 72 
using novel statistics, DVxy and SVxy.  We also develop an isolation-index (Isx) 73 
that predicts the overall level of such key genetic characteristics and can thus 74 
help guide population choice in future complex-trait association studies.  75 
 76 
 77 
Introduction 78 
 79 
Population variation in disease susceptibility has been shaped by environment, 80 
demography and evolutionary history. Isolated populations (isolates) have 81 
generally experienced bottlenecks and strong genetic drift, so by chance some 82 
deleterious rare variants have increased in frequency while some neutral rare 83 
variation is lost, both helpful characteristics for the discovery of novel rare variant 84 
signals underpinning complex traits1-3. Studies to date have focused on individual 85 
isolates and have identified several disease-associated signals4-12. However, isolates 86 
differ in the time when they became isolated, their initial population size, the level 87 
of gene flow from outside and other historical demographic factors, and 88 
consequently also differ in their power for association studies2. We thus generate 89 
and analyze low-depth (4x-10x) whole-genome sequences (WGS) from eight cohorts 90 
drawn from isolated European populations and compare each isolate with the 91 
closest non-isolated (general) population, for which we also generate or access WGS 92 
data. We then investigate empirically how these historical differences influence the 93 
population-genetic properties of isolates, and frame these insights in terms of their 94 
consequences for study design in complex trait association studies.  95 
 96 
 97 
Results 98 
 99 
Samples, sequencing and QC. The dataset includes newly-generated low-depth 100 
(4x-10x) WGS from eight cohorts drawn from isolated European populations: one 101 
each from Kuusamo in Finland (FIK) and Crete in Greece (GRM13), four from Friuli-102 
Venezia Giulia in Italy (IF1, IF2, IF3 and IF414), and one each from Val Borbera in 103 
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Italy (IVB15) and the Orkney Islands in the UK (UKO16); and the closest non-isolated 104 
(general) population: Finland (FIG9), Greece (GRG), together with publicly available 105 
data for Italy (ITG17) and UK (UKG18) (Fig. 1a and Supplementary Table 1). We 106 
generated a superset of variants called in these cohorts and all 26 population 107 
samples in the 1000 Genomes Project Phase 317, and performed multi-sample 108 
genotype calling across all 9375 samples (3059 from the current study, 2353 from 109 
the 1000 Genomes Project Phase 3 release, and 3781 from UK10K). Both individual 110 
population and amalgamated genotype call data, which have greater than 99% 111 
concordance with genotyping data (Supplementary Table 2), are available to the 112 
scientific community (Data availability).   113 
 114 
General description of the variants in the isolates. We identified approximately 115 
12.2 million (M) variants with minor allele frequency (MAF) ≤2% (rare), 5.5M with 116 
MAF >2-≤5% (low-frequency) and 8.3M variants with MAF >5% (common) across 117 
the 10 populations newly sequenced here (eight isolates, GRG and FIG). Of these, 118 
10.5%, 0.7% and 0.3%, respectively, are novel (Table 1 and Supplementary Table 3). 119 
As expected, most of the isolates have lower numbers of variant sites per genome 120 
than their closest general population (Supplementary Fig.1, Supplementary Table 5). 121 
We find ~188,000-~513,000 variants that are common with MAF >5.5% in each 122 
isolate but with MAF ≤1.4% in its closest general population (Table 1); ~30,000-123 
122,000 of these per isolate have frequency ≤1.4% in all the general samples 124 
studied, among which ~150-~700 in coding regions and ~500-~2800 genome-wide 125 
are deleterious (Supplementary Table 4).  These common and low-frequency 126 
variants are thus useful markers for whole-genome association studies in these 127 
populations and some of them (if absent from the general population) could 128 
potentially lead to novel association signals. They include known examples such as 129 
rs76353203 (R19X) in APOC3 in GRM, which is associated with high-density 130 
lipoprotein and triglyceride levels6. 131 
 132 
Population-genetic analyses in the isolates. Previous population-genetic studies 133 
of isolates have, with some exceptions11,19, been based on common variants found 134 
on genotyping arrays, and have illustrated general characteristics such as low 135 
genetic diversity and longer shared haplotypes9,13-15,19,20. Rare variants discovered 136 
from sequencing are on average more recent in origin than common variants21 and  137 
therefore more powerful for distinguishing closely-related populations and more 138 
informative about recent demographic history. We find that isolates are, as expected, 139 
genetically close to their matched general population in principal component 140 
analyses (PCA), ADMIXTURE22 and TreeMix23 using common variants (Fig. 1b, 141 
Supplementary Figs. 2-5 and Supplementary Table 6), but PCA using rare and low-142 
frequency variants, as found previously24, distinguishes them more clearly from the 143 
general population and also from other isolates, particularly among the Italian 144 
samples (Fig. 1c, Supplementary Fig. 2). The majority of sharing of variants present 145 
just twice across all samples of 36 individuals from each population (f2 variants21) 146 
takes place within the same population, and the isolates generally share more with 147 
their closest general population than with other populations. This latter trend, 148 
however, is not apparent for IF1-IF4, who show little sharing with any other 149 
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population, pointing to a greater level of isolation and lower level of gene flow with 150 
their general population (Fig. 1d, lower triangle and Supplementary Fig. 7), which is 151 
confirmed by f3-statistics25 comparing with a worldwide population panel of HGDP-152 
CEPH samples using common SNPs (Supplementary Fig. 6). f3-f10 variant sharing 153 
demonstrates sharing by ITG and IVB with both Greek and UK populations (Fig. 1d, 154 
upper triangle and Supplementary Fig. 7), potentially indicative of their more 155 
ancient heritage. 156 
 157 
Population demographic history. All populations studied here, both isolates and 158 
general, appear to have shared a comparable effective population size (Ne)history 159 
before 20 thousand years ago (KYA) based on the multiple sequentially Markovian 160 
coalescent (MSMC) method26 (Supplementary Fig. 9). The isolates diverged from 161 
their general populations within the last ~5000 years based on LD estimations27 162 
(Supplementary Table 7 and Supplementary Fig. 8) and yet had sharp decreases in 163 
their population sizes in more recent times as estimated using inferred long 164 
segments of identity by descent (IBD)28 (Fig. 1e, f and Supplementary Fig.10). 165 
Different isolates also split from their respective general populations at different 166 
times. For example, IF1-IF4 split from ITG ~4-5 KYA, while most other isolates split 167 
from their general populations within the last ~1,000 years (Supplementary Table 168 
7).   169 
 170 
The different demographic histories of different isolates should lead to different 171 
genetic characteristics. To summarize these features in a single quantitative 172 
measure that can be calculated from genotype data, as well as sequence data, we 173 
developed an isolation index (Isx) which combines information on the divergence 174 
time from the general population (Tdg), Ne and migration rate (M), such that early-175 
divergence-time isolates with small Ne and low M have a high Isx value (Fig. 2a and 176 
Supplementary Fig. 11). The different isolates show different Isx values: IF1, IF2, IF3 177 
and IF4 have the highest, while IVB has the lowest (Supplementary Table 8). Isx 178 
values are highly correlated with other population-genetic characteristics (e.g. Fig. 179 
2b, c, Supplementary Table 11), such as genome-wide pairwise FST between isolates 180 
and their matching general population (reflecting the genetic drift of the isolates) 181 
(Supplementary Fig. 12), the total length and number of runs of homozygosity 182 
(ROH) (Supplementary Fig. 13), inbreeding coefficient (F) (Supplementary Fig. 14) 183 
and length of LD (Supplementary Figs. 15-16 and Supplementary Table 9, 10). All 184 
these characteristics are correlated, but the pairwise correlation coefficients show 185 
that Isx is a slightly better overall predictor of the other measures than any single 186 
existing measure (Fig. 2c, Supplementary Fig. 17 and Supplementary Table 11); 187 
moreover, it is potentially more robust to confounding factors as it is calculated 188 
from three demographic parameters, while the others are all based on single 189 
measurements.  190 
 191 
Purifying selection analyses. Several lines of evidence suggest relaxed purifying 192 
selection in the isolates due to their reduced Ne, although as expected we do not 193 
detect substantially increased genetic load per genome using the Rxy statistic29 194 
based on all of the variants in the genomes (Fig. 3a and Supplementary Table 12). 195 
6 
 
First, we see different levels of enrichment of low-frequency functional variants in 196 
isolates (Fig. 3b and c, Supplementary Tables 13 and14, Supplementary Figs. 18a) 197 
quantified by a new statistic, DVxy-coding, developed here (DV: drifted variants). 198 
DVxy-coding measures the ratio of functional coding variants (missense plus loss-of-199 
function (LoF)) in isolates compared to the closest general population (and vice-200 
versa), adjusted for the corresponding ratios of intergenic variants in order to 201 
correct for the effect of genetic drift. We applied this only to a subclass of DVs, 202 
defined as low-frequency (2-5%, the best choice according to the sample size we 203 
have) in any isolate, yet at least three-fold higher than in the closest general 204 
population (and vice versa). We find that DVxy-coding is >1 in all isolates and <1 in 205 
all general populations (Fig. 3c, Supplementary Fig. 18a and Supplementary Table 206 
13). We also calculated a similar DVxy-wg statistic by stratifying whole-genome 207 
variants according to their combined annotation dependent depletion (CADD) score 208 
(0-5, neutral variants; 5-10, mildly deleterious; 10-20, deleterious; and >20, highly 209 
deleterious; these cut-off choices balance the number of variants in each bin to allow 210 
us comparable statistical power among all bins, although the conclusions are robust 211 
to the particular cut-off values chosen and different bins (Supplementary Figs. 18b  212 
and Supplementary Fig. 19)). The DVxy-wg values are differentiated for variants 213 
with CADD score of 10-20 and significantly so (assessed using the jack-knife 214 
bootstrap method) for ones with CADD scores >20, with DVxy-wg values >1 in all 215 
isolates and <1 in all general populations (Fig. 3b, Supplementary Fig. 18b and 216 
Supplementary Table 14). This demonstrates enrichment of low-frequency 217 
functional variants, both coding and genome-wide with CADD score >10, in the 218 
isolated populations. Moreover, both DVxy-coding and DVxy-wg values are 219 
correlated with Isx, suggesting that different isolation characteristics lead to 220 
different levels of enrichment of functional variants.  221 
 222 
We also investigated the relaxation of purifying selection by assessing functional 223 
(missense) singleton variants (SV) pooled for all of the genes that have at least one 224 
singleton missense or synonymous variant in a pair of populations (one isolate and 225 
its general population), correcting with pooled synonymous variants (SVxy statistic,). 226 
We find a substantial deviation from 1 for functional singletons in all of the isolates 227 
(Fig. 3d and Supplementary Table 15), with SVxy values positively correlating with 228 
Isx (Fig. 2c and Supplementary Fig. 20). We also find that the proportion of relaxed 229 
essential genes30 with SVxy >1 in isolates is significantly higher than in the general 230 
population (Supplementary Table 15). Such rare and low-frequency drifted 231 
functional variants, measured by both SVxy and DVxy, are particularly relevant for 232 
boosting the power of association studies6.  233 
 234 
Positive selection analyses. We do not find convincing evidence for positive 235 
selection in any isolate using deltaDAF31, PCAdapt32 or SDS33, although we do 236 
identify some highly differentiated variants (Supplementary Fig. 21 and 237 
Supplementary Tables 16,17), including in the protein-coding genes ALK, SPNS2, 238 
SLC39A11 and ACSS2, which can nevertheless be accounted for by drift.  239 
Interestingly, we also find six highly-differentiated variants shared between 240 
different isolates from Italy, IF2, IF3 and IF4, but interpret them as likely to result 241 
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from drift or positive selection for the ancestral allele in the ITG (Supplementary 242 
Table 17). We find that the SDS method has little power in our samples because of 243 
their small size, and failed to detect selection even at the lactose tolerance SNP in 244 
the UKO, a known strong signal of recent selection (Supplementary Fig. 22). 245 
 246 
 247 
Discussion  248 
 249 
Isolated populations have special characteristics that can be leveraged to increase 250 
the power of association studies, as several previous studies have shown19,34. 251 
Nevertheless, only a small proportion of functional variants have increased in 252 
frequency in any one isolate, so multiple isolates must be investigated to reveal the 253 
full diversity of associated variants. Here, we probed an extended allele frequency 254 
spectrum of variants potentially underpinning human complex disease through the 255 
analysis of whole-genome sequence data in multiple isolates matched to nearby 256 
non-isolated populations, capturing common, low-frequency and rare variants. We 257 
quantified different levels of isolation resulting from different demographic 258 
histories and have demonstrated that the Isx statistic, calculated even from SNP-chip 259 
data, reliably captures these relevant features. This study provides a systematic 260 
evaluation of the genetic characteristics of multiple European isolates and for the 261 
first time empirically demonstrates enrichment of rare functional variants across 262 
multiple isolates. With the advent of large-scale whole-genome sequencing, studies 263 
in isolates are poised to continue as major contributors to our understanding of 264 
complex disease etiology.  265 
 266 
 267 
Methods 268 
 269 
Dataset and variant calling: The dataset includes 3059 whole-genome low-depth 270 
sequences generated at The Wellcome Trust Sanger Institute using the Illumina 271 
Genome Analyzer II and Illumina HiSeq 2000 platforms, as well as 100 high-depth 272 
sequences from the Illumina HiSeq X Ten (Fig. 1a and Supplementary Table 1). 273 
Informed consent was obtained from all subjects and the study was approved by the 274 
HMDMC (Human Materials and Data Management Committee) of the Welcome Trust 275 
Sanger Institute. The multi-sample genotype calling across all of the low-coverage 276 
sequencing data from the current study, as well as 2353 from the 1000 Genomes 277 
Project Phase 3 release, and 3781 from UK10K (a total of 9375) was performed with 278 
the defined site selection criteria (Supplementary Note). Genotype likelihoods were 279 
calculated with samtools/bcftools (0.2.0-rc9) and then genotypes were called and 280 
phased using Beagle v4 (r1274)35. We assessed the performance of the genotype 281 
calling from the low coverage data using the available genotype chip data for a 282 
subset of the cohorts consisting of 4665 individuals, and calculated the discordance 283 
rates on chromosome 20 separately for the categories REF-REF, REF-ALT and ALT-284 
ALT. 285 
 286 
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The sample sizes are very different across these collections, and we used three 287 
different standard-sized subsets of the samples for different analyses: (1) the whole 288 
dataset; (2) the sample-size-matched dataset, obtained either by randomly selecting 289 
samples from general population to match the isolated population (for example, we 290 
randomly select 377 from FIG to match FIK), or by randomly selecting a subset of 291 
the isolated population to match the general population (for example, we randomly 292 
select 108 IVB to match the general population ITG); (3) the minimum-sample-size 293 
dataset of 36 individuals per population. By doing this, we maximize the use of the 294 
data for different analyses, and we specify which dataset is used for each analysis. 295 
The sequencing depth is also different across different populations, within a 2.5-fold 296 
range (apart from GRG, in which variants were called differently, details in 297 
Supplementary Notes), and we allowed for these differences when interpreting the 298 
results. 299 
 300 
Variant counts: We first re-annotated all variants using the Variant Effect Predictor 301 
(VEP) annotation from Ensembl 76 with the “- pick” option, which gives one 302 
annotation per variant. We then performed variant counting at both the population 303 
and individual level, stratifying by functional categories and frequency bins. These 304 
counts were either plotted in figures or summarized as median values in tables. We 305 
carried out these analyses using both the sample-size-matched dataset and the 306 
minimum-sample-size dataset. 307 
 308 
Population-genetic analyses: We used the whole dataset for the analyses in this 309 
section, unless otherwise specified. Principal component analyses (PCAs) were 310 
performed separately with common variants or rare variants using EIGENSTRAT 311 
v.50136.  Shared ancestry between the populations studied here was evaluated using 312 
ADMIXTURE v1.2222. The relationships between the populations studied here, 313 
combined with worldwide populations from the HGDP-CEPH panel37, were also 314 
examined using ancestry graph analyses implemented in TreeMix v.1.1223. We also 315 
used formal test of f3-satitisitcs25 to investigate population mixture in the history of 316 
the populations studied here, as well as worldwide populations from the HGDP-317 
CEPH panel. Rare f2 variants (with only two copies of the alternative allele in the 318 
minimum-sample-size dataset) and moderately rare f3-10 variants (3-10 copies of the 319 
alternative allele in the same dataset) are particularly informative for investigating 320 
recent human history21. We investigated the sharing pattern of these two types of 321 
variant by summing all f2 variants or any random two alleles of the f3-10 variants 322 
shared by pairs of individuals. We plotted the results as a heat map using the image¹ 323 
function from the base R package (https://stat.ethz.ch/R-manual/R-324 
devel/library/graphics/html/image.html). Variants were aggregated by pair of 325 
individuals using the ‘count’ function of the plyr package, then arranged in matrix 326 
form and colorized using ‘colorRampPalette’ from the colorspace package 327 
(https://cran.r-project.org/web/packages/colorspace/index.html). Runs of 328 
homozygosity (ROH),  inbreeding coefficient (F) as well as the length of LD-blocks 329 
were calculated in PLINK, and finally genome-wide FST values between isolates and 330 
their general populations were calculated with the software 4P38 using the 331 
minimum-sample-size dataset.  332 
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 333 
Demographic inferences: LD-based39-41 demographic inference was performed in 334 
the NeON R package27 using the minimum-sample-size dataset; the median and 335 
confidence interval were estimated using the 50th, 5th and 95th percentiles of the 336 
distribution of long-term Ne in each time interval. We used the multiple sequentially 337 
Markovian coalescent (MSMC) method26 to infer demographic changes before 338 
20,000 years ago using four individual sequences from each population. In order to 339 
account for some loss of heterozygous sites in the low-depth data, we used a slow 340 
mutation rate of 0.8 x 10-8 mutations per nucleotide per generation and a longer 341 
generation time of 33 years. We then estimated more recent demographic changes 342 
(from the present to ~9,000 years ago) using IBDNe28 with the minimum-sample-343 
size dataset. We used IBDseq42 to detect IBD segments in sequence data from 344 
chromosome 2 in all populations. We then used IBDNe with the default parameters 345 
and a minimum IBD segment length of 2 centiMorgan (cM) units. We assumed a 346 
generation time of 29 years. 347 
 348 
Isolation index: In order to quantify the different isolation levels of different 349 
isolates, we developed an index that combines three demographic parameters: (a) 350 
Tdg, (b) Ne, and (c) the level of private isolate ancestry (M). We call this estimate the 351 
Isolation index (Isx). It is defined as: 352 
 353 
ܫݏݔ = log(ܶ݀݃(100 ∗ ܯ)
ଶ)
log(ܰ݁)  
 354 
Both Tdg and Ne were inferred from the LD-based method using the NeON R 355 
package27. M is difficult to estimate directly from SNP genotype data, so here we 356 
estimated the difference of shared ancestral components between an isolate and its 357 
general population from ADMIXTURE analysis. We ran ADMIXTURE with only one 358 
isolate and it closest general population using K=2. We then estimated the difference 359 
in the means of ancestry between the isolate and its general population. The M 360 
parameter was defined as Delta Ancestry. 361 
 362 
Rxy analysis: Rxy statistics29 between each pair of populations (an isolate and its 363 
closest general population) for different functional categories were calculated using 364 
the matched-sample-size data for missense and LoF variants, including stop gain, 365 
splice donor and acceptor variants, using synonymous variants as controls (we did 366 
not use intragenic variants as control because of the ascertainment in the ITG which 367 
has high-depth exome sequences and low depth for the rest of the genome). We also 368 
calculated Rxy statistics for variants with CADD scores43 greater than 10 and 20, 369 
using variants with CADD scores less than 5 as controls. The mean and standard 370 
deviation for each Rxy value were obtained from 100 bootstraps.  371 
 372 
DVxy analysis: A new statistic, DVxy, was developed to quantify the enrichment of 373 
low-frequency functional variants in the isolates using both the matched-sample-374 
size and minimum-sample-size datasets. It calculates the proportion of functional 375 
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variants in each isolate compared with its general population, correcting for genetic 376 
drift at the same time. We calculated DVxy specifically for the subset of variants with 377 
DAF 2-5% in the isolate, and at least three times lower in its closest general 378 
population, or vice-versa. We called these variants “drifted variants” (DV). DVxy was 379 
calculated for both coding regions and whole genomes.  380 
 381 
For coding variants, we defined missense or missense plus LoF variants as 382 
functional variants.  We counted the number of functional DVs and neutral 383 
(intergenic) DVs in each isolate (population x) and the corresponding general 384 
population (population y). The ratio between the fraction of DV variants from the 385 
isolated population (corrected by the count of intergenic variants) and the 386 
corresponding fraction of DV variants from its general population was defined as 387 
the DVxy statistic. If DVxy is equal to 1, there is no enrichment for the functional DVs 388 
in the isolate; less than 1 indicates depletion, and greater than 1 indicates 389 
enrichment. 390 
                    391 
ܦܸݔݕ_ܿ݋݀݅݊݃ =
%ܦܸݔ ݉݅ݏݏ݁݊ݏ݁
%ܦܸݔ ݅݊ݐ݁ݎ݃݁݊݅ܿ 
%ܦܸݕ ݉݅ݏݏ݁݊ݏ݁
%ܦܸݕ ݅݊ݐ݁ݎ݃݁݊݅ܿ
൙   
 392 
For the whole genome, we used different CADD score cut-offs and bins. We 393 
calculated a DV statistic by stratifying the variants according to their CADD scores 394 
(0-5, neutral variants; 5-10, mildly deleterious; 10-20, deleterious; and greater than 395 
20, highly deleterious) for each isolate and its closest general population. We finally 396 
calculated a ratio of the fraction of DV variants (from each class) between the isolate 397 
and its general population, and vice-versa. The following formula shows the DVxy-398 
wg calculation for variants with CADD score between i (isolate) and j (general 399 
population). 400 
 401 
ܦܸݔݕ஼஺஽஽(௜௝) = % ܦܸݔ (ܥܣܦܦ ݅ − ݆) %ܦܸݕ(ܥܣܦܦ ݅ − ݆)൘  
 402 
The 95% confidence interval for each calculation was obtained by randomly 403 
sampling data from 20 chromosomes 100 times.  404 
 405 
SVxy analysis: We further investigated the relaxation of purifying selection in the 406 
isolated populations using singleton variants. Here, we also used the minimum-407 
sample-size dataset. Another new statistic, SVxy, was developed to measure the ratio 408 
of missense vs synonymous singletons per gene in each population, as well as the 409 
ratio of the sum of singletons in all genes which have at least one singleton in the 410 
pair of the populations (one isolate and one general population). We counted the 411 
number of missense singletons and synonymous singletons per gene in each 412 
population, and SVgene was calculated as: 413 
 414 
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SVgene = (SV missense count +1)/ (SV synonymous count +1) 415 
 416 
SVgene >1 indicates relaxation of purifying selection; SVgene = 1 indicates 417 
neutrality; and SVgene <1 indicates purifying selection.  418 
 419 
We then divided the gene list into essential genes30 and non-essential genes (the 420 
rest), and calculated a statistic, GSV, for each population, defined as: 421 
 422 
GSV = percentage of essential genes with SVgene >1/percentage of non-essential 423 
genes with SVgene >1 424 
 425 
We finally calculated a statistic, SVxy, which is the ratio of SVpop of each isolate to 426 
SVpop of its general population. SVpop for each isolate and its general population 427 
was calculated using all genes which have at least one singleton in the pair of the 428 
populations and defined as SVpop = Σ (SV missense counts)/Σ(SV synonymous 429 
counts). 430 
 431 
We used the same annotation as in the variant counts. We calculated a confidence 432 
interval for each estimate using bootstrapping of 80% of the genes 100 times. 433 
 434 
Correlation analyses: We calculated pair-wise correlation coefficients between the 435 
Isx values, population-genetic measurements ROH, F, FST, and number and length of 436 
LD blocks, as well as the newly-developed statistics DVxy and SVxy using the 437 
Pearson correlation in R. 438 
 439 
Positive selection analyses: We calculated genome-wide pairwise derived allele 440 
frequency differences (deltaDAF) for each pair of populations (an isolate and its 441 
general population) as described previously31 using the matched-sample-size 442 
dataset. We also carried out PCAdapt analyses32 for each pair of populations using 443 
the whole dataset. Both analyses look for high derived allele frequency variants in 444 
the isolates, and will not be affected by sample size. Finally, we ran the singleton 445 
density score (SDS) method33 using the whole UKO and UKG datasets, which have 446 
the largest sample sizes for both isolate and its general population, and thus the 447 
greatest power for this method. 448 
 449 
Data availability: 450 
 451 
Amalgamated genotype calls across all populations studied are available through 452 
the European Genome/Phenome Archive (EGAD00001002014) with Data Access 453 
Agreement described in the Supplementary Information. 454 
 455 
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Figure legends 606 
 607 
 608 
Fig. 1. General characteristics and demographic history of isolated and matched 609 
general populations. a. Geographical locations of samples. The base map was plotted 610 
in R using the mapdata package and circles were added using Photoshop. b. PCA 611 
using common variants. c. PCA using low-frequency variants. d. Sharing of rare 612 
variants within and between populations. Upper left triangle: f2 variants; lower right 613 
triangle f3-f10 variants. e. Effective population size (Ne) inferred from IBDNe for UKO 614 
and UKG during the past 9 KY. f. The lowest Ne inferred by IBDNe for all populations 615 
for the past 3KY, plotted as a function of the time at which it occurred.  616 
 617 
Fig. 2. Isolation index (Isx) and its correlation with other genetic measures. a. 618 
Information summarized in Isx. b. Example of the correlation between Isx and other 619 
statistics, here DVxy-coding. c. Summary of the correlations between Isx and other 620 
population-genetic statistics. All the correlation coefficients are high and statistically 621 
significant.  622 
 623 
Fig. 3. Purifying selection in the isolates and general populations. a. Rxy-missense 624 
statistic in each isolate, showing no evidence for increased genetic load in the 625 
isolates. The mean and standard deviation for each Rxy value from 100 bootstraps 626 
are shown. b. DVxy-wg (DVxy-whole genome) statistic in isolates and general 627 
populations, stratified by CADD score, showing enrichment of highly-functional low-628 
frequency variants. c. DVxy-coding statistic in isolates and general populations, 629 
showing enrichment of low-frequency missense variants in isolates. d. SVxy-630 
missense statistic in each isolate, showing relaxation of purifying selection in 631 
isolates in singletons. The standard errors for both DVxy and SVxy were calculated 632 
by randomly sampling data from 20 chromosomes 100 times. All of these analyses 633 
are based on the minimum-sample-size dataset (36 individuals from each 634 
population). 635 
  636 
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Tables: 637 
  638 
Table 1. Summary of variants discovered in this study 639 
 640 
 641 
‘Novel’ variants are those not found in 1000 Genomes Project Phase 3 or UK10K 642 
project. *Variants that are common (minor allele frequency, MAF ≥5.6%, alternative 643 
allele count ≥ 4) in an isolated population but not common (MAF <1.4%, alternative 644 
allele count ≤ 1) in its closest general population. **Variants that are common (MAF 645 
≥5.6%, alternative allele count ≥ 4) in an isolated population but not (MAF <1.4%, 646 
alternative allele count ≤ 1) in any of the general populations. ***Different variant 647 
calling procedure in this population.  648 
 649 
 650 
 651 
 652 
POP n average 
depth 
MAF ≤2% MAF >2-≤5% MAF >5% Novel 
common 
SNPs in 
isolate* 
Novel 
common 
SNPs in 
isolate** 
   total novel
% 
total novel
% 
total novel
% 
  
FIK 377 4x 4,066,373 10.90 1,553,076 1.20 6,025,077 0.70 190,527 70,579 
FIG 1564 6x 6,548,833 11.80 1,540,915 0.80 6,053,704 0.70 n.a. n.a. 
GRM 249 4x 5,129,513 7.20 1,447,981 1.10 6,111,923 0.80 513,272 49,884 
GRG*** 99 10-30x 3,757,110 n.a. 1,321,955 n.a. 5,842,537 n.a. n.a. n.a. 
IF1 60 4-10x 1,456,881 1.30 1,420,929 1.30 5,890,714 0.80 320,191 119,157 
IF2 45 4-10x 1,063,098 1.30 1,554,145 1.00 6,001,568 0.80 273,694 94,496 
IF3 47 4-10x 961,059 1.30 1,455,284 1.10 6,068,304 0.80 299,603 107,281 
IF4 36 4-10x 1,030,673 1.30 1,124,789 1.10 6,001,625 0.80 308,356 122,254 
IVB 222 6x 4,857,767 1.60 1,396,799 0.80 6,112,476 0.80 188,972 30,284 
UKO 397 4x 5,963,416 11.70 1,471,782 0.80 6,047,383 0.80 193,300 36,512 
Total 3096  12,218,797 10.50 5,503,179 0.70 8,301,524 0.30  



